tag:www.schizophrenia.com,2009:/cgi-bin/mt//feed/Seroquel 2009-11-22T08:57:18Z Movable Type 4.24-en 23 1 23 tag:www.schizophrenia.com,2008:/sznews//13.6154 2008-03-31T18:50:12Z 2008-04-01T14:30:50Z szadmin www.schizophrenia.com Second generation "Atypical" antipsychotic drugs are not much better than the older, less expensive Haldol treating a first episode of schizophrenia, according to a study done by Dutch researchers that was published in the British Medical journal "The Lancet". However,... tag:www.schizophrenia.com,2007:/sznews//13.5281 2007-07-13T18:06:17Z 2007-08-22T21:28:58Z http://www.schizophrenia.com There are two new research studies recruiting participants at the Clinical Research Unit at the University of North Carolina at Chapel Hill: Following is a description of each of the studies: GLAD - Prevention of Postpsychotic Depression with Lamotrigine Who... tag:www.schizophrenia.com,2007:/sznews//13.5119 2007-06-01T14:20:00Z 2007-07-09T20:27:34Z Naomi_NJW http://www.schizophrenia.com Dr. Henry A. Nasrallah, an expert in the field of schizophrenia treatment, was inteviewed by Medscape to discuss results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) as well as Britain's Cost Utility of the Latest Antipsychotic Drugs in... tag:www.schizophrenia.com,2007:/sznews//13.5088 2007-05-18T17:15:21Z 2007-05-19T00:07:55Z Naomi_NJW http://www.schizophrenia.com The U.S. Food and Drug Administration (FDA) has approved Seroquel (quetiapine fumarate) XR extended-release tablets for the treatment of schizophrenia. Seroquel XR is a product of AstraZeneca. The new extended-release formulation of Seroquel is intended as a once-daily medicine for... tag:www.schizophrenia.com,2006:/sznews//13.4291 2006-11-30T16:18:35Z 2006-11-30T20:48:39Z szadmin www.schizophrenia.com The FDA's Division of Drug Marketing, Advertising and Communications, in a Nov. 16 letter (see below) to AstraZeneca, said the material is "false and misleading" because it minimized the risk of diabetes and did not adequately communicate the risk of... tag:www.schizophrenia.com,2006:/sznews//13.3685 2006-07-25T06:47:35Z 2006-07-25T07:16:29Z szadmin www.schizophrenia.com Schizophrenia.com member Rcourtade noted that on July 18th it was announced that AstraZeneca had submitted a New Drug Application (NDA) to the US Food and Drug Administration for a sustained release (SR) once-daily formulation of Seroquel for the treatment of... tag:www.schizophrenia.com,2006:/sznews//13.3275 2006-04-12T20:34:42Z 2006-12-20T01:39:20Z szadmin www.schizophrenia.com Earlier this week we covered the release of the results from the CATIE 2 drug comparison study funded by the National Institute of Mental Health. Instead of focusing on how some symptom or side effect waxes and wanes, the government... tag:www.schizophrenia.com,2005:/sznews//13.2438 2005-09-22T01:43:37Z 2005-09-22T02:10:36Z szadmin www.schizophrenia.com The results from the CATIE study that were made public the other day (see CATIE STUDY RESULTS) are provoking a great deal of discussion and analysis in the world of people impacted by schizophrenia - as it well should. The... tag:www.schizophrenia.com,2005:/sznews//13.2424 2005-09-20T19:42:38Z 2005-09-27T15:41:57Z szadmin www.schizophrenia.com The Wall Street Journal reported this morning that "Old Schizophrenia Drug Works As Well as Newer Treatments" In the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) results an older, less expensive antipsychotic drug known as Perphenazine (Trilafon) worked almost as... tag:www.schizophrenia.com,2005:/sznews//13.2416 2005-09-17T16:52:28Z 2005-09-17T17:44:25Z szadmin www.schizophrenia.com Its been reported that this coming Thursday (September 22nd) will see the publishing of the CATIE trial results - the biggest ever government study comparing the safety and efficacy of four big-selling schizophrenia treatments. It is expected to be published... tag:www.schizophrenia.com,2005:/sznews//13.2311 2005-08-24T01:08:02Z 2005-08-24T02:37:31Z http://www.schizophrenia.com A new study suggests that using the drug topiramate in addition to antipsychotic medication may be helpful for 10%-20% of those with treatment-resistant schizophrenia. According to the researchers in the study less than 50% of those suffering from schizophrenia get... tag:www.schizophrenia.com,2005:/sznews//13.2172 2005-07-27T21:41:39Z 2005-07-29T19:14:22Z http://www.schizophrenia.com In the coming months the results of a recently-completed study funded by the National Institutes of Mental Health (NIMH) will be published. The study is called CATIE, "The Clinical Antipsychotic Trials of Intervention Effectiveness project" and is comprised of four... tag:www.schizophrenia.com,2005:/sznews//13.2072 2005-07-09T04:13:40Z 2005-07-09T20:55:28Z Seroquel is effective against aggression in patients with schizophrenia The majority of people suffering from schizophrenia are not violent. However, there seems to be a misconception about the disorder, in that many people perceive those suffering from schizophrenia as being... tag:www.schizophrenia.com,2005:/sznews//13.1991 2005-06-26T23:07:57Z 2007-08-13T17:25:29Z SCHIZOPHRENIA; Seroquel and risperidone improve cognitive function Recently, results from a new study conducted by AstraZeneca, show that Seroquel and risperidone are effective "in improving cognitive function, such as memory and attention, in patients with schizophrenia." Though, this is good... tag:www.schizophrenia.com,2005:/sznews//13.1970 2005-06-23T10:45:18Z 2006-12-20T01:42:45Z J&J's Risperdal Linked to Increased Tumour Risk Though we've already covered Johnson & Johnson's development of new antipsychotics to some extent, recently some new studies concerning the effects of their antipsychotic Risperdal have been made public. These "preliminary studies," conducted... tag:www.schizophrenia.com,2005:/sznews//13.1947 2005-06-16T06:50:53Z 2006-12-20T01:44:01Z Schizophrenia And Medication Side Effects Recently there has been a lot of news about the medications used for treating schizophrenia. From Florida's possible drug restrictions for Medicaid patients to Eli Lilly's recent "announcement to spend $690 million to end lawsuits... tag:www.schizophrenia.com,2005:/sznews//13.1628 2005-04-12T12:18:46Z 2005-04-13T04:46:49Z szadmin www.schizophrenia.com FDA Warning on Antipsychotic Drugs for Elderly suffering from Dementia The U.S. Food and Drug Administration warned Monday that "off-label" -- unapproved -- use of certain drugs used to treat behavioral disorders such as schizophrenia can be potentially fatal to... tag:www.schizophrenia.com,2005:/sznews//13.1561 2005-03-25T02:26:03Z 2007-08-13T17:26:12Z szadmin www.schizophrenia.com Early reports are good on Akzo Nobel's new schizophrenia and bipolar disorder drug called Asenapine, currently in Phase-III trials, (Phase III trials are the final stage of the FDA drug approval process, but there are no guarantees that the drug... tag:www.schizophrenia.com,2004:/sznews//13.1011 2004-09-17T08:13:08Z 2006-12-20T01:20:37Z The following is a press release from Acadia Pharmaceuticals, detailing the clinical testing of a new drug that allegedly reduces some side effects associated with haloperidol, Zyprexa, Risperdal and Seroquel. As with all cases where you're getting information directly from... tag:www.schizophrenia.com,2004:/sznews//13.2913 2004-09-01T01:57:35Z 2006-01-12T23:15:40Z http://www.schizophrenia.com Safety and Efficacy of Long-Acting Risperidone in Schizophrenia: A 12-Week, Multicenter, Open-Label Study in Stable Patients Switched From Typical and Atypical Oral Antipsychotics. Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M. J Clin Psychiatry. 2004 Aug;65(8):1084-1089. Pharmaceutical companies have recently...